| Kroger Pharmacy #520 | |
| 1771e Michigan Ave, Ypsilanti, Michigan 48198 | |
| (734) 482-9342 |
| Name | Kroger Pharmacy #520 |
|---|---|
| Organization Name | Kroger Co Of Michigan |
| Location | 1771e Michigan Ave, Ypsilanti, Michigan 48198 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (734) 482-9342 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Underuse of effective treatments for mental health disorders is more pronounced among African Americans than non-Hispanic whites.
Dicerna Pharmaceuticals, Inc., a second generation RNA interference company developing novel therapeutics utilizing its proprietary Dicer Substrate Technology™ and Dicer Substrate siRNA molecules, today announced that it has closed a $25 million Series B round of financing. New investor Domain Associates led the round, with all existing investors participating - Oxford Bioscience Partners, Skyline Ventures and Abingworth.
Premature babies are born during their third trimester and they are vulnerable to having brain bleeds because their brains are not completely developed. There are some fragile blood vessels that are present in every developing infant, but when the babies are born early, these blood vessels can be subject to changes in blood pressure and changes in breathing patterns and, due to their fragility, they can develop a hemorrhage.
Analysis from business intelligence provider GBI Research - Type 1 Diabetes Mellitus Therapeutics in Major Developed Markets to 2021 - states that the global market value for T1DM treatment will rise from $4.2 billion in 2014 to $7.1 billion by 2021, at a robust Compound Annual Growth Rate (CAGR) of 7.9%.
› Verified 6 days ago
| NPI Number | 1124052998 |
| Organization Name | KROGER CO OF MICHIGAN |
| Doing Business As | KROGER PHARMACY |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 1771 E Michigan Ave, Ypsilanti, MI 48198 |
| Phone Number | 734-482-9342 |
News Archive
Underuse of effective treatments for mental health disorders is more pronounced among African Americans than non-Hispanic whites.
Dicerna Pharmaceuticals, Inc., a second generation RNA interference company developing novel therapeutics utilizing its proprietary Dicer Substrate Technology™ and Dicer Substrate siRNA molecules, today announced that it has closed a $25 million Series B round of financing. New investor Domain Associates led the round, with all existing investors participating - Oxford Bioscience Partners, Skyline Ventures and Abingworth.
Premature babies are born during their third trimester and they are vulnerable to having brain bleeds because their brains are not completely developed. There are some fragile blood vessels that are present in every developing infant, but when the babies are born early, these blood vessels can be subject to changes in blood pressure and changes in breathing patterns and, due to their fragility, they can develop a hemorrhage.
Analysis from business intelligence provider GBI Research - Type 1 Diabetes Mellitus Therapeutics in Major Developed Markets to 2021 - states that the global market value for T1DM treatment will rise from $4.2 billion in 2014 to $7.1 billion by 2021, at a robust Compound Annual Growth Rate (CAGR) of 7.9%.
› Verified 6 days ago
News Archive
Underuse of effective treatments for mental health disorders is more pronounced among African Americans than non-Hispanic whites.
Dicerna Pharmaceuticals, Inc., a second generation RNA interference company developing novel therapeutics utilizing its proprietary Dicer Substrate Technology™ and Dicer Substrate siRNA molecules, today announced that it has closed a $25 million Series B round of financing. New investor Domain Associates led the round, with all existing investors participating - Oxford Bioscience Partners, Skyline Ventures and Abingworth.
Premature babies are born during their third trimester and they are vulnerable to having brain bleeds because their brains are not completely developed. There are some fragile blood vessels that are present in every developing infant, but when the babies are born early, these blood vessels can be subject to changes in blood pressure and changes in breathing patterns and, due to their fragility, they can develop a hemorrhage.
Analysis from business intelligence provider GBI Research - Type 1 Diabetes Mellitus Therapeutics in Major Developed Markets to 2021 - states that the global market value for T1DM treatment will rise from $4.2 billion in 2014 to $7.1 billion by 2021, at a robust Compound Annual Growth Rate (CAGR) of 7.9%.
› Verified 6 days ago
Rite Aid Pharmacy 04363 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 753 S Grove St, Ypsilanti, Michigan 48198 Phone: (734) 482-7430 | |
Cvs Pharmacy #16629 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3749 Carpenter Rd, Ypsilanti, Michigan 48197 Phone: (734) 975-4675 | |
Cvs Pharmacy #08165 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2151 Washtenaw Rd, Ypsilanti, Michigan 48197 Phone: (734) 483-8900 | |
Cvs Pharmacy # 01758 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 5408 Whittaker Rd, Ypsilanti, Michigan 48197 Phone: (734) 481-3381 | |
Cvs Pharmacy #08083 Type: Pharmacy Location: 3090 Carpenter Rd, Ypsilanti, Michigan 48197 Phone: (734) 973-7402 |